Home > Drug Search >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
chemistry (70) biology (19)
Clinical Stage:
Pending (3) Active (60) Discontinued (1)
Bio-Type:
CAR T cell therapy (1) Recombinant cytokines (1) Whole antibody (12) ADC (1) Fusion protein (1)
Company:
Hansoh Pharma (1) Jiangsu Hengrui Medicine (4) Lee's Pharm (1) Merck Serono (1) National Cancer Institute (1) Roche (2) Sanhome Pharmaceutical (1) Sanofi (1) Sinopharm A-THINK Pharmaceutical (1) WuXi AppTec (1) Kite Pharma (1) Zhongsheng Pharmacy (1) Innovent Biologics (2) Genor Biopharma (3) Liaoning Haisike pharmaceutical (1) Livzon Group Livzon Pharmaceutical Factory (2) Hangzhou Zhongmei Huadong Pharmaceutical (1) Kelun Pharmaceutical (2) Suzhou Dawnrays Pharmaceutical (1) Sichuan Haisco Pharmaceutical (1) Penglai Nuokang Pharmaceutical (1) Zhaoke Pharmaceutical (1) XuanZhu Pharma (1) Fochon Pharmaceuticals (1) Suzhou Sirnaomics Biopharmaceuticals (1) Institute of Pharmacology & Radiation of AMMS (1) Beijing Fengshuo Weikang (1) Baiyunshan Pharmaceutical (1) Zhejiang Yongning Pharmaceutical (2) BBCA Pharmaceutical (1) Bossan (1) Chongqing University of Arts and Sciences (1) Cisen Pharmaceutical (1) Tianjin Institute of Pharmaceutical Research (1) Jianfeng Pharmaceutical (1) Kanion Pharmaceutical (2) Nanjing Advenchen Laboratories (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Shanghai Genomics (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Eleven (1) Institute of Pharmacology & Toxicology of AMMS (1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2) China Pharmaceutical University (1) HEC Pharm (1) Huadong Medicine (1) Shanghai Haihe Pharmaceutical (1) Fosun Pharma (1) ImQuest BioSciences (1) Shenyang Pharmaceutical University (1) 302 Military Hospital of China (1) Third Military Medical University (1) Tasly Pharm (1) Immune Pharmaceuticals (1) Bio-Thera Solutions (1) Shanghai Pharma (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Sirnaomics (1) Guangzhou Xiangxue Pharmaceuticals (1) Shandong Provincial Institute of Dermatology and Venereology (1) Hangzhou Pharmavaxin (1) Guangzhou Yinnuo Pharmaceutical (1) Fujian Jinshon Biologicalpharmaceutical (1) Hangzhou Adamerck Pharmlabs (2) Shanghai Newsummit Biopharma (2) Shanghai Xianfu Chemical Technology (1) Ocean University of China (1) Nanjing Tech University (1) 浙江浙北药业 (1) Innocare (1) Zhejiang Forever Medicine (1) TOT Biopharm (1) Foreland Pharma (1) Ajanta Pharma (1) Jingfeng Pharma (1) Zhaoke Oncology (1) Hangzhou Advenchen Laboratories (1) Ningbo Shengjian (1) Shanghai Hengrui (3) Hangzhou Tianlong Pharmaceuticals (1) Dongguan Anhao (1) Dongguan Daxin (1) Jiangsu Shengdi (1) Southeast Pharmaceuticals (1) GNI Group (1) 吉林英联尚德科技开发 (1) Sichuan Saizhuo Pharmaceutical (1) Akeso Biopharma (1) Huabo Biopharm (1) Chongqing Fujin Biomedical (1) MabSpace Biosciences (1) Buchang Pharma (1) Dalian Dien Biological Engineering (1) Suzhou Kanger Biopharmaceutical (1) Anke Biotechnology (1) NuoKang Biopharma (1) Beijing Ruiyunhai Biotechnology (1) Jiangsu Medolution (1) Zhejiang University (1) BCN Peptides (1) DiverDrugs (1) Teligene (1) Puyi chemical/Gyrochem (1) Signum Dermalogix (1) Dermata (1) Beijing Molike Technology (1) Chengdu Yiping Pharmaceutical Technology (1) Sichuan Yibin Wuliangye Yibin Pharmaceutical (1) Qingdao University (1) Wuhan Kangliyuan (1) Techfields Pharma (1) Beijing Collab Pharma (1) Heng Kang (1) Samjin (1) Gmax Biopharm (1) Shanghai Allist Pharmaceuticals (1) Chiatai Tianqing (CTTQ) (2)
Indication:
Acne (2) Alzheimer's disease (AD) (1) Arrhythmia (1) Brain ischemia (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Chronic pain (1) Diabetic macular edema (1) Endometrial cancer (1) Endometriosis (1) Epilepsy/Seizures (1) Erectile dysfunction (ED) (1) Gastric cancer (3) Generalized tonic-clonic status epilepticus (GTCSE) (1) Glioblastoma multiforme (1) Gram-positive and Gram-negative bacterial infections (1) HBV infection (1) HCV infection (3) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypercholesterolemia (1) Hyperlipidemia (1) Hypertension (1) Leukemia (1) Lung cancer (3) Melanoma (1) Metastatic colorectal cancer (CRC) (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (7) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (2) Osteoarthritis (OA) (2) Pancreatic cancer (1) Parkinson's disease (PD) (1) Postmenopausal osteoporosis (1) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (5) Solid tumours (11) Stable plaque psoriasis (1) Systemic lupus erythematosus (1) Tuberculosis (1) Type 2 diabetes (7) Uveitis (1) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Systemic bacterial infections (3) Chronic heart failure (2) Malignant Ascites (1) Age-related macular degeneration (AMD) (1) Pain (1) Anesthesia (1) Bone metastases from solid tumors (2) HER2-positive metastatic breast cancer (2) Renal carcinoma (1) Hyperphosphatemia (1) Gram-positive bacterial infection (1) Gastrointestinal motility disorders (1) Ischemic stroke (1) Gout (1) Thrombosis (1) Alopecia (1) Skin hypertrophic scars (1) Bacterial infection (1) Urinary tract stones (1) HER2-positive breast cancer (1) Liver cancer (1) Liver failure (1) Giant cell tumor of bone (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top